Icovamenib
Icovamenib is an investigational irreversible covalent inhibitor of menin. It is developed by Biomea Fusion for diabetes, lymphoma, leukemia, and multiple myeloma Multiple myeloma (MM), also known as plasma cell myeloma and simply myeloma, is a cancer of plasma cells, a type of white blood cell that normally produces antibody, antibodies. Often, no symptoms are noticed initially. As it progresses, bone .... References {{reflist Covalent inhibitors 4-Morpholinyl compounds Pyrrolopyrimidines Disubstituted pyridines Piperidines Acrylamides Carboxamides ...
[...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]